comparemela.com

Latest Breaking News On - Institutional trading of elevance health - Page 2 : comparemela.com

Elevance Health, Inc. (NYSE:ELV) Short Interest Up 9.9% in January

Elevance Health, Inc. (NYSE:ELV – Get Free Report) was the target of a large growth in short interest during the month of January. As of January 31st, there was short interest totalling 2,110,000 shares, a growth of 9.9% from the January 15th total of 1,920,000 shares. Based on an average daily volume of 1,110,000 shares, […]

Canada
Royal-bank
Elevance-health-stock
Securities-exchange-commission
Elevance-health-inc
Fortis-capital-advisors
Householder-group-estate-retirement-specialist
Elevance-health-company-profile
Wealth-advisors
News-ratings-for-elevance-health-daily
Jpmorgan-chase-co

Ramiro G. Peru Sells 753 Shares of Elevance Health, Inc. (NYSE:ELV) Stock

Elevance Health, Inc. (NYSE:ELV – Get Free Report) Director Ramiro G. Peru sold 753 shares of the stock in a transaction dated Wednesday, February 7th. The stock was sold at an average price of $500.00, for a total value of $376,500.00. Following the completion of the sale, the director now directly owns 9,109 shares of […]

Alaska
United-states
Canada
Alaska-permanent-fund-corp
Elevance-health-increases-dividend
Fortis-capital-advisors
Cantor-fitzgerald
Royal-bank
Elevance-health
Jpmorgan-chase-co
Morgan-stanley

Elevance Health (NYSE:ELV) PT Raised to $574.00

Elevance Health (NYSE:ELV – Get Free Report) had its target price boosted by research analysts at Royal Bank of Canada from $572.00 to $574.00 in a report issued on Thursday, Benzinga reports. The brokerage currently has an “outperform” rating on the stock. Royal Bank of Canada’s price objective suggests a potential upside of 18.64% from […]

Canada
Institutional-trading-of-elevance-health
Keener-financial-planning
Elevance-health-company-profile
Cerity-partners
Elevance-health-inc
Carr-financial-group-corp
Royal-bank
Cantor-fitzgerald
Elevance-health-stock
Investment-advisors-inc

StockNews.com Downgrades Elevance Health (NYSE:ELV) to Buy

Elevance Health (NYSE:ELV – Get Free Report) was downgraded by stock analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a report issued on Thursday. A number of other research analysts have also commented on the company. Royal Bank of Canada upped their price objective on Elevance Health from $572.00 to $574.00 […]

Canada
Analyst-recommendations-for-elevance-health
Elevance-health
Td-capital-management
Jpmorgan-chase-co
Householder-group-estate-retirement-specialist
Wealth-advisors
Fortis-capital-advisors
Morgan-stanley
Elevance-health-company-profile
Elevance-health-stock

Elevance Health (NYSE:ELV) PT Raised to $574.00

Elevance Health (NYSE:ELV) PT Raised to $574.00
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Canada
Moors-cabot-inc
Morgan-stanley
Cantor-fitzgerald
Analyst-recommendations-for-elevance-health
Institutional-trading-of-elevance-health
Royal-bank
Brown-brothers-harriman-co
News-ratings-for-elevance-health-daily
Elevance-health
Elevance-health-price-performance
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.